CN115315530A - 使用特定基因中cpg甲基化改变以诊断膀胱癌的组合物及其用途 - Google Patents

使用特定基因中cpg甲基化改变以诊断膀胱癌的组合物及其用途 Download PDF

Info

Publication number
CN115315530A
CN115315530A CN202180023436.0A CN202180023436A CN115315530A CN 115315530 A CN115315530 A CN 115315530A CN 202180023436 A CN202180023436 A CN 202180023436A CN 115315530 A CN115315530 A CN 115315530A
Authority
CN
China
Prior art keywords
methylation
bladder cancer
gene
march11
iffo1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180023436.0A
Other languages
English (en)
Chinese (zh)
Inventor
赵相来
文永镐
韩振日
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gencurix Inc
Original Assignee
Gencurix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gencurix Inc filed Critical Gencurix Inc
Publication of CN115315530A publication Critical patent/CN115315530A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
CN202180023436.0A 2020-01-28 2021-01-28 使用特定基因中cpg甲基化改变以诊断膀胱癌的组合物及其用途 Pending CN115315530A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020200010053A KR102637032B1 (ko) 2020-01-28 2020-01-28 특정 유전자의 CpG 메틸화 변화를 이용한 방광암 진단용 조성물 및 이의 용도
KR10-2020-0010053 2020-01-28
PCT/KR2021/001154 WO2021154009A1 (ko) 2020-01-28 2021-01-28 특정 유전자의 CpG 메틸화 변화를 이용한 방광암 진단용 조성물 및 이의 용도

Publications (1)

Publication Number Publication Date
CN115315530A true CN115315530A (zh) 2022-11-08

Family

ID=77078172

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180023436.0A Pending CN115315530A (zh) 2020-01-28 2021-01-28 使用特定基因中cpg甲基化改变以诊断膀胱癌的组合物及其用途

Country Status (6)

Country Link
US (1) US20230084248A1 (https=)
EP (1) EP4098755A4 (https=)
JP (1) JP7828613B2 (https=)
KR (1) KR102637032B1 (https=)
CN (1) CN115315530A (https=)
WO (1) WO2021154009A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118147311A (zh) * 2024-05-13 2024-06-07 北京橡鑫生物科技有限公司 尿路上皮癌甲基化标志物试剂盒

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023083348A1 (zh) * 2021-11-15 2023-05-19 武汉艾米森生命科技有限公司 用于食管癌诊断的甲基化检测试剂及试剂盒
CN116168761B (zh) * 2023-04-18 2023-06-30 珠海圣美生物诊断技术有限公司 核酸序列特征区域确定方法、装置、电子设备及存储介质
CN118230812A (zh) * 2023-12-15 2024-06-21 王姝瑶 一种精确筛查的基因检测方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120101023A1 (en) * 2009-04-20 2012-04-26 Erasmus University Medical Center Rotterdam Method of diagnosing bladder cancer
WO2016108403A1 (ko) * 2014-12-30 2016-07-07 충북대학교 산학협력단 방광암 예후 진단 마커로서 ｒｓｐｈ９의 용도
US20180148776A1 (en) * 2015-02-24 2018-05-31 Zymo Research Corporation Assays to determine dna methylation and dna methylation markers of cancer
CN108350504A (zh) * 2015-06-24 2018-07-31 Ucl商业有限公司 膀胱癌的诊断方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001077375A2 (en) 2000-04-06 2001-10-18 Epigenomics Ag Diagnosis of diseases associated with gene regulation
US20090298054A1 (en) * 2004-07-18 2009-12-03 Epigenomics Ag Epigenetic methods and nucleic acids for the detection of breast cell proliferative disorders
EP2311984A1 (en) * 2004-12-02 2011-04-20 Epigenomics AG Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disorders
EA013634B1 (ru) * 2005-04-15 2010-06-30 Эпиджиномикс Аг Способы и нуклеиновые кислоты для анализов клеточных пролиферативных нарушений
EP2147124A4 (en) * 2007-04-11 2010-07-14 Manuel Esteller EPIGENETIC BIOMARKERS FOR EARLY DETECTION, EFFICIENT TREATMENT AND RETENTION OF CANCER
US8399193B2 (en) * 2007-08-30 2013-03-19 City Of Hope DNA methylation biomarkers for lung cancer
EP2390371A1 (en) * 2007-11-30 2011-11-30 Genomictree, Inc. Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene
MX2011000655A (es) * 2008-07-18 2011-03-21 Oragenics Inc Composiciones para la deteccion y tratamiento de cancer colorrectal.
EP2233590A1 (en) * 2009-01-28 2010-09-29 AIT Austrian Institute of Technology GmbH Methylation assay
US20130065228A1 (en) * 2011-06-01 2013-03-14 University Of Southern California Genome-scale analysis of aberrant dna methylation in colorectal cancer
US9096905B2 (en) * 2012-02-23 2015-08-04 Medical Diagnostic Laboratories, Llc Detecting DNA methylation of BCL2, CDKN2A and NID2 genes to predict bladder cancer in humans
WO2017201606A1 (en) * 2016-05-04 2017-11-30 Queen's University At Kingston Cell-free detection of methylated tumour dna
US11207340B2 (en) * 2017-05-26 2021-12-28 The Chinese University Of Hong Kong Tumor suppressor TET1 and uses thereof
WO2019195941A1 (en) * 2018-04-13 2019-10-17 London Health Sciences Centre Research Inc. Dna methylation assays and methods
MX2020013994A (es) * 2018-06-22 2021-05-27 Bluestar Genomics Inc Análisis de hidroximetilación de muestras de ácido nucleico sin células para asignación de tejido de origen, y métodos relacionados de uso.
US10249912B1 (en) 2018-07-18 2019-04-02 Lg Chem, Ltd. Electrical control system

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120101023A1 (en) * 2009-04-20 2012-04-26 Erasmus University Medical Center Rotterdam Method of diagnosing bladder cancer
WO2016108403A1 (ko) * 2014-12-30 2016-07-07 충북대학교 산학협력단 방광암 예후 진단 마커로서 ｒｓｐｈ９의 용도
US20180148776A1 (en) * 2015-02-24 2018-05-31 Zymo Research Corporation Assays to determine dna methylation and dna methylation markers of cancer
CN108350504A (zh) * 2015-06-24 2018-07-31 Ucl商业有限公司 膀胱癌的诊断方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BRENNA ANE: "Identification of novel epigenetic masterkeys in cancer - with potential diagnostic value", 《DUO RESEARCH ARCHIVE》, 31 May 2014 (2014-05-31) *
HYUNG-YOON YOON等: "RSPH9 methylation pattern as a prognostic indicator in patients with non-muscle invasive bladder cancer", 《ONCOL REP》, vol. 35, no. 2, 11 November 2015 (2015-11-11), pages 1195 - 203, XP055832508, DOI: 10.3892/or.2015.4409 *
MIHAELA CAMPAN等: "Genome-Scale Screen for DNA Methylation-Based Detection Markers for Ovarian Cancer", 《PLOS ONE》, vol. 6, no. 12, 7 December 2011 (2011-12-07), pages 28141 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118147311A (zh) * 2024-05-13 2024-06-07 北京橡鑫生物科技有限公司 尿路上皮癌甲基化标志物试剂盒

Also Published As

Publication number Publication date
EP4098755A1 (en) 2022-12-07
JP2023513039A (ja) 2023-03-30
KR20210096509A (ko) 2021-08-05
KR102637032B1 (ko) 2024-02-15
US20230084248A1 (en) 2023-03-16
EP4098755A4 (en) 2024-06-26
JP7828613B2 (ja) 2026-03-12
WO2021154009A1 (ko) 2021-08-05

Similar Documents

Publication Publication Date Title
CN108350504B (zh) 膀胱癌的诊断方法
CN101675171B (zh) 用basp1基因和/或srd5a2基因中的甲基化胞嘧啶检测肝癌、肝癌风险、肝癌复发风险、肝癌恶化和肝癌随时间进展的方法
CN110387420B (zh) 用于子宫内膜癌诊断的试剂盒以及应用
US20150361502A1 (en) Method for screening cancer
JP7828613B2 (ja) 特定の遺伝子のＣｐＧメチル化の変化を利用した膀胱癌診断用組成物およびその使用
CN110387421A (zh) 用于肺癌检测的DNA甲基化qPCR试剂盒及使用方法
JP2024020392A (ja) 特定の遺伝子のｃｐｇメチル化変化を利用した肝癌診断用組成物およびその使用
WO2010118559A1 (zh) 一种癌症筛检的方法
TW202142549A (zh) 腫瘤檢測試劑及試劑盒
CN110484621A (zh) 一种肝癌早期预警的方法
EP4647511A1 (en) Gene marker combination, kit, and detection method
KR20260008061A (ko) GLRB 유전자의 CpG 메틸화 변화를 이용한 대장암, 직장암 또는 대장 선종 진단용 조성물 및 이의 용도
CN113355415B (zh) 用于食管癌诊断或辅助诊断的检测试剂及试剂盒
KR20210044441A (ko) 특정 유전자의 CpG 메틸화 변화를 이용한 대장암, 직장암 또는 대장 선종 진단용 조성물 및 이의 용도
CN116144782A (zh) 一种用于肺癌检测的组合标志物及其应用
US11535897B2 (en) Composite epigenetic biomarkers for accurate screening, diagnosis and prognosis of colorectal cancer
US20230383356A1 (en) Composition for diagnosing colorectal cancer, rectal cancer or colorectal adenoma by using cpg methylation change of linc01798 gene, and use thereof
CN114107498A (zh) 结直肠癌血液检测标记物及其应用
CN119193832A (zh) 用于检测卵巢癌的组合物及其用途
CN111662980A (zh) 一种肺癌检测试剂及试剂盒
CN117431321A (zh) 一种用于前列腺癌或癌前病变检测的核酸组合物、试剂盒及应用
CN109868320A (zh) 用于检测食道癌的组合物及其用途
KR20230105973A (ko) 특정 유전자의 CpG 메틸화 변화를 이용한 전립선암 진단용 조성물 및 이의 용도
CN115961048B (zh) 一种基因甲基化检测引物组合、试剂及其应用
TWI753455B (zh) 用以評估個體罹患胃癌或癌前病變之風險的方法、其套組、其分析器及其生物標誌

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination